#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Primary progressive multiple sclerosis

Recruiting

Investigational

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational

France

Participants:18–64 years

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Gastrooesophageal cancer+1

Recruiting

Registered drugNo placebo

A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:FRUQUINTINIB

Contact Research Centre

Schizophrenia

Recruiting

InvestigationalNo placebo

Study on Brain Inflammation in Schizophrenia Patients Using 18F-DPA-714

InvestigationalNo placebo

France

Participants:18–64 years · Healthy volunteers
Substances:N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide

Contact Research Centre

Huntington's disease

Recruiting

InvestigationalNo placebo

Study on [18F]MNI-659 to Track Huntington's Disease Progression in Symptomatic and Pre-symptomatic Patients

InvestigationalNo placebo

France

Participants:18–64 years · Healthy volunteers
Substances:2-[2-[3-[4-(2-(18F)FLUORANYLETHOXY)PHENYL]-7-METHYL-4-OXOQUINAZOLIN-2-YL]ETHYL]-4-PROPAN-2-YLOXYISOINDOLE-1,3-DIONE

Contact Research Centre

Multiple sclerosis

Recruiting

InvestigationalNo placebo

Study of [18F]-DPA-714 PET imaging to assess neuroinflammation in multiple sclerosis patients compared to healthy controls

InvestigationalNo placebo

France

Participants:18–64 years · Healthy volunteers
Substances:N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide

Contact Research Centre

Rectal cancer+2

Recruiting

Registered drugNo placebo

Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Septic shock

Recruiting

Registered drug

A Study of Levetiracetam for Prevention and Treatment of Delirium in Adult ICU Patients with Septic Shock

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Levetiracetam

Contact Research Centre

Appendicitis+1

Recruiting

Registered drugNo placebo

Study on Post-Surgery Antibiotic Use in Patients with Complicated Acute Appendicitis: Evaluating Metronidazole, Ceftriaxone, and Ofloxacin Hydrochloride

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ceftriaxone Sodium

Contact Research Centre

Hyponatraemia+1

Recruiting

Registered drugNo placebo

Study on Using Desmopressin Acetate Trihydrate to Prevent Sodium Overcorrection in Patients with Severe Hyponatremia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Glucose

Contact Research Centre

Depression

Recruiting

Registered drugNo placebo

Study on the Early Effects of Ketamine and Venlafaxine for Hospitalized Patients with Severe Major Depression

Registered drugNo placebo

France

Participants:18–64 years
Substances:Ketamine

Contact Research Centre

Small intestine adenocarcinoma

Recruiting

Registered drugNo placebo

Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Levofolinate

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.